Teva officially shutters the doors to a troubled Southern California site
While FDA investigators earlier this year found issues at Teva Pharmaceuticals’ plant in Irvine, CA, forcing the company to padlock the doors, the company has decided to pull the plug on reopening it.
According to a California Worker Adjustment and Retraining Notification (WARN) notice, Teva is axing 305 jobs at the site, which has had a multitude of issues, and permanently closing it.
Last year the site received a Form 483 from the FDA that led to the recall of more than 2.5 million vials of drugs that might not be sterile. The inspection found that untreated water damage likely led to mold generating in the walls, and Teva took a few steps to prevent the further spread of mold and bacteria throughout the site.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.